How Werfen is driving Innovation in Immunoassays

Innovation is one of the strategic and fundamental Biokit pillars and we innovate at all levels, regarding biomaterials, assays, and manufacturing biotechnology processes. We aim to reinforce immunoassay know-how and technology capabilities, keeping in mind a final goal: increase efficiency and robustness, reduce time to market and/or streamline operations.

In Werfen, we enjoy, promote and benefit from a unique network of scientists, entrepreneurs and major players in the IVD sector allowing us to identify and incorporate the most innovative tools and technologies, that will be key in order to move your immunoassay portfolio one-step beyond.

Join us in the webinar Next-Generation IgM Immunoassays, to hear how Biokit is driving innovation in Immunoassays through the case of a development of a next-generation IgM immunoassay using different approaches to reach the defined goals for this new IgM immunoassay .